COBLL1 and breast cancer: To further examine the correlation of Cobll1/PACSIN2/SH3BP1 with BC progression, we analyzed the clinical characteristics of 51 patients at the BC phase based on distinct combinatorial expression patterns of Cobll1/PACSIN2/SH3BP1 including bone marrow blast percentage.